Citations

Clear

3314 citation(s) found for "Yu, Alexander".

Real-world clinical effectiveness and safety of olaparib monotherapy in HER2-negative gBRCA-mutated metastatic breast cancer: Phase IIIb LUCY interim analysis.
Fasching, Peter A. , Gelpí, Judith Balmaña, McCutcheon, Susan , Ano, Sabine, O’Shaughnessy, Joyce , Gelmon, Karen A. , Couch, Fergus J. , Delaloge, Suzette , Labidi‐Galy, Sana Intidhar , Bennett, James

Mayo Clinic

Journal of Clinical Oncology | May 25, 2020 | Volume: 38 | Issue: 15_suppl | Pages: 1087-1087

10.1200/jco.2020.38.15_suppl.1087 Get It

1087 Background: OlympiAD (NCT02000622) demonstrated the benefit of olaparib over standard of care in patients (pts) with HER2-negative (HER2-) metastatic breast cancer (MBC) and germline BRCA mutations (gBRCAm). LUCY (NCT03286842) aimed to provide additional data on the real-world effectiveness and safety of olaparib monotherapy in this setting. Methods: This Phase IIIb, open-label, single-arm study of olaparib 300 mg twice-daily, enrolled pts with HER2- gBRCAm MBC who had received a taxane and/or anthracycline in the (neo)adjuvant/metastatic setting, and ≤2 lines of chemotherapy for MBC. Hormone receptor-positive (HR+) pts had progressed on prior endocrine therapy (ET), and further ET was considered unsuitable. Primary endpoint: investigator-defined progression-free survival (PFS). Secondary endpoints: overall survival, time to first subsequent therapy or death (TFST), and investigator-assessed clinical response rate (CRR). The interim analysis was planned after 160 PFS events. Results: From Oct 2018-Sept 2019, 252 pts were enrolled (160 sites, 15 countries; mean age 46.2 [range 22-75] years; 73.4% ECOG PS 0). Median total treatment duration: 7.9 months (mo; range 0.2-20.0). Median PFS: 8.1 mo (95% confidence interval [CI] 6.9, 8.7; 166 events [65.9%]). Clinical trial information: NCT03286842 . Median TFST: 9.7 mo (95% CI 8.7, 11.1). CRR: 48.6% (95% CI 42.2, 55.0). Adverse events (AEs) in >20% of pts (all grades): nausea, anemia, asthenia, vomiting, and fatigue. 24.6% of pts reported a grade ≥3 AE, including anemia (n=33 [13.1%]). 4.4% of pts had an AE leading to treatment discontinuation. Conclusions: Interim results in this real-world population of pts with HER2- gBRCAm MBC were consistent with the OlympiAD study, and support olaparib as a chemotherapy-free alternative treatment for pts with gBRCAm advanced BC. [Table: see text]
Disparities in Objective Sleep Quality as Assessed Through Wrist Actigraphy in Minority Patients With Inflammatory Bowel Disease
Qazi, Taha , Alexander, Megan , Wu, Ting , Noronha, Ansu, Jones, Eric A., Smith, Alexander , Hammer, David A. , Auerbach, Sanford H. , Wasan, Sharmeel K. , Weinberg, Janice , Farraye, Francis A.

Mayo Clinic

Inflammatory Bowel Diseases | May 25, 2020 | Volume: 27 | Issue: 3 | Pages: 371-378

10.1093/ibd/izaa106 | PMID 32448906 Get It

Abstract Background Inflammatory bowel disease (IBD) is associated with a reduced quality of life. Minority patients with IBD specifically report more impairing symptoms compared with nonminority patients. Sleep quality, a key component of quality of life, is significantly compromised in minority patients compared with nonminority patients. Nevertheless, subjective and objective sleep assessments in minority patients with IBD have not explicitly been assessed. The purpose of this prospective cohort study is to assess and compare objective sleep parameters utilizing wrist actigraphy between minority and nonminority IBD patients. Methods In this institutional review board approved study, 74 patients with IBD were recruited and stratified into 2 cohorts by self-identification: white nonminority patients and minority patients. Patients in the minority cohort included black and Hispanic individuals (black and nonblack). Exclusion criteria included significant comorbidity, a history of an underlying sleep disorder, or patients who did not self-identify into categorized cohorts. Sleep was measured not only through wrist-based actigraphy but also with sleep surveys. Sleep parameters were compared between minority and nonminority cohorts. Regression analyses were performed to assess for factors independently associated with parameters of poor sleep quality. Results Sixty-four patients (86.4%) were included in the final analysis. Thirty-one individuals (48.4%) were categorized into the nonminority cohort, and 33 (51.6%) patients were in the minority cohort. A significantly higher number of minority patients had poorer sleep efficiency and fragmented sleep compared with nonminority patients (90.9% vs 67.7%; P = 0.03 and 87.8% vs 61.3%; P = 0.02). In the adjusted analysis, minority status was independently associated with poor sleep efficiency (odds ratio = 6.41; 95% confidence interval, 1.48-28.17; P = 0.0139) and fragmented sleep (odds ratio = 4.98; 95% confidence interval, 1.09-22.89; P = 0.0389). Conclusions Minority patients with IBD were shown to have poorer objective measures of sleep as assessed through wrist actigraphy compared to nonminority patients. Cultural competency in the care of minority patients with IBD, specifically focusing on the management of psychosocial issues, is needed to address these disparities in sleep. The inclusion of minority patients with IBD in studies investigating sleep and other psychosocial issues are warranted not only to assess potential disparities in disease course but also to determine the etiologies of poor sleep in minority patients with IBD.
Comparing the Efficacy of Syngeneic Iliac and Femoral Allografts with Iliac Crest Autograft in a Rat Model of Lumbar Spinal Fusion
Elder, Benjamin D. , Pantoja, Alexander Perdomo, Locke, John , Cottrill, Ethan , Lo, Sheng-Fu Larry , Holmes, Christina , Ishida, Wataru , Witham, Timothy F.

Mayo Clinic

No container title available | May 12, 2020 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-27369/v1 Get It

Abstract Background: Despite widespread use of femoral-sourced allografts in clinical spinal fusion procedures and the increasing interest in using femoral reamer–irrigator–aspirator (RIA) autograft in clinical bone grafting, few studies have examined the efficacy of femoral grafts compared to iliac crest grafts in spinal fusion. The objective of this study was to directly compare the use of autologous iliac crest with syngeneic femoral and iliac allograft bone in the rat model of lumbar spinal fusion.Methods: Single-level bilateral posterolateral intertransverse process lumbar spinal fusion surgery was performed on Lewis rats divided into three experimental groups: iliac crest autograft; syngeneic iliac crest allograft; and syngeneic femoral allograft bone. Eight weeks postoperatively, fusion was evaluated via microCT analysis, manual palpation and histology. In vitro analysis of the colony-forming and osteogenic capacity of bone marrow cells derived from rat femurs and hips was also performed to determine whether there was a correlation with the fusion efficacy of these graft sources.Results: Although no differences were observed between groups in CT fusion rates or fusion mass volumes, iliac allografts displayed a higher rate of bilateral fusion via manual palpation. Histologically, hip-derived grafts showed better integration with host bone than femur derived ones, likely associated with the higher concentration of osteogenic progenitor cells observed in hip-derived bone marrow.Conclusions: This study demonstrates the feasibility of using syngeneic allograft bone in place of autograft bone within inbred rat fusion models and highlights the need for further study of femoral-derived grafts in fusion.
Abstract QS16: Revascularization Patterns Of Nerve Allografts In A Rat Sciatic Nerve Defect Model
Saffari, Tiam M. , Mathot, Femke , Bishop, Allen T. , Shin, Alexander Y.

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | May 12, 2020 | Volume: 8 | Issue: 4S | Pages: 146-147

10.1097/01.gox.0000667920.01532.60 Get It

Abstract 127: Combined Local Delivery Of Tacrolimus And Stem Cells In Fibrin Gel Is A Viable Potential Treatment For Enhancing Peripheral Nerve Regeneration
Saffari, Tiam M. , Chan, Katelyn, Zuo, Kevin J. , Chan, Katelyn, Borschel, Gregory Howard , Shin, Alexander Y.

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | May 12, 2020 | Volume: 8 | Issue: 4S | Pages: 85-85

10.1097/01.gox.0000667564.21860.79 Get It

Abstract 122: Surgical Angiogenesis To Nerve Allografts Improves Early Functional Recovery In A Rat Sciatic Nerve Defect Model
Saffari, Tiam M. , Mathot, Femke , Bishop, Allen T. , Shin, Alexander Y.

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | May 12, 2020 | Volume: 8 | Issue: 4S | Pages: 81-81

10.1097/01.gox.0000667544.80702.77 Get It

Improving Resident Satisfaction with Post-Hospitalization Follow-up at Mayo Clinic Florida
Melody, Megan , Espinosa, Samantha , Mareth, Karl , Gardner, Lindsay B., Heckman, Alexander , Mechtler, Annamaria G., Killebrew, SeQuoya R., Dudgeon, Matthew, White, Richard O. , Speicher, Leigh L.

Mayo Clinic

No container title available | May 11, 2020 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.158921583.30982457 Get It

Rationale, aims, and objectives: Post-hospitalization follow-up within 30 days following discharge has been shown to positively impact time to readmission, healthcare costs, and patient self-reported adherence and satisfaction. We aimed to improve resident satisfaction with the process of establishing post-hospitalization, primary care provider (PCP) follow-up. Methods: In this quality improvement study we surveyed all internal medicine residents at our institution regarding their satisfaction with the process of establishing PCP follow-up at the time of hospital discharge. A streamlined process was developed and two subsequent interventions were enacted; a dedicated teaching session and distribution of pocket cards outlining the process. Residents were then surveyed following each intervention to assess for impact on overall satisfaction and burden of work. Results: Initially, 77.3% of residents were not satisfied with the process of establishing post-hospitalization PCP follow-up. Following the first intervention there was a trend towards increasing satisfaction rates by 16.7% (p= 0.20), and after the second intervention there was a statistically significant increase in satisfaction rates from baseline by 44% (p= 0.007). There was also a reduction in the feeling of workload burden associated with establishing PCP follow-up from 32% to 25%, and over 67% of participants either agreed or strongly agreed that the workload was not too burdensome. Conclusion: This quality improvement initiative established that resident physicians at our institution previously found the process of establishing PCP follow-up at the time of patient discharge both confusing and burdensome. Through the implementation of our interventions we were able to achieve our aims of improving resident satisfaction.
PWE-076 Efficacy of Pharmacological Therapies in Patients with Irritable Bowel Syndrome with Diarrhoea: Network Meta-analysis
Black, Christopher J. , Camilleri, Michael , Ford, Alexander C. , Ford, Alexander C , Black, Christopher J , Burr, Nicholas Ewin , Earnest, David, Quigley, Eamonn M.M. , Moayyedi, Paul , Houghton, Lesley A.

Mayo Clinic

Posters | May 8, 2020 | Volume: No volume available | Issue: No issue available | Pages: A207.2-A208

10.1136/gutjnl-2019-bsgabstracts.396 Get It

Role of tacrolimus in return of hand function after brachial plexus injury in a lung transplantation patient
Saffari, Tiam M. , Arendt, Christopher, Spinner, Robert J. , Arendt, Christopher J, Shin, Alexander Y.

Mayo Clinic

BMJ Case Reports | May 7, 2020 | Volume: 13 | Issue: 5 | Pages: e233788

10.1136/bcr-2019-233788 | PMID 32381527 Get It

We report a patient who has been on tacrolimus for bilateral lung transplantation and presented with a brachial plexus injury (BPI), with unusual improvement of lower trunk innervated hand function. The lower trunk injury with resultant left hand paralysis had developed after his sternotomy 18 months ago. He has been treated with tacrolimus as part of his immunosuppression protocol since the surgery, without severe side effects. Physical examination at 18 months demonstrated unusual excellent grip pattern and full opposition of his thumb with slight claw deformity of his ulnar two digits. While the neurotoxic effects of tacrolimus are more emphasised, the neuroregenerative properties have been recently explored. The recovery in this patient is unique and unusual after BPI and is most likely as a result of the low dose tacrolimus treatment.